Ep04.01 a Theoretical Study on the Efficacy and Mechanism of Combined Yap-1 and Parp-1 Inhibitors in the Treatment of Glioblastoma Multiforme Using Peruvian Maca (lepidium Meyenii)
Year: 2025
Type: conference-abstract
Abstract: BACKGROUND Glioblastoma multiforme (GBM) is one of the most aggressive and treatment-resistant forms of brain cancer. Current therapeutic strategies, including surgery, chemotherapy, and radiotherapy, often fail due to the tumor’s ability to develop resistance. The proteins YAP-1 (Yes-associated protein 1) and PARP-1 (Poly-(ADP-ribose)-polymerase-1) have been implicated in this resistance, playing crucial roles in cell proliferation and DNA repair mechanisms, respectively. MATERIAL AND METHODS This study explored the inhibitory potential of natural compounds from Lepidium meyenii (Peruvian Maca) on the YAP-1 and PARP-1 protein systems to develop novel therapeutic strategies for GBM. By molecular dynamics simulations, we identified N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide (DK5) as the most promising natural inhibitor for PARP-1 and stearic acid (GK4) for YAP-1 RESULTS Although synthetic inhibitors, such as Olaparib (ODK) for PARP-1 and Verteporfin (VER) for YAP-1, only VER was superior to the naturally occurring molecule and proved a promising alternative. CONCLUSION In conclusion, natural compounds from Lepidium meyenii (Peruvian Maca) offer a potentially innovative approach to improve GBM treatment, complementing existing therapies with their inhibitory action on PARP-1 and YAP-1
Source: Neuro-Oncology
Authors: A Turpo Peqqueña, S Luna Prado, R Valencia Arce, F Del Carpio-Carrazco, B Gomez, J Turpo Peqqueña, G Huanca-Quispe, R Hernandez Mayori
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: bronze
OpenAlex ID: W4414792485
Cites:
Cited by:
Related to: